These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 16034446

  • 1. Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex.
    Gilbert DL, Ridel KR, Sallee FR, Zhang J, Lipps TD, Wassermann EM.
    Neuropsychopharmacology; 2006 Feb; 31(2):442-9. PubMed ID: 16034446
    [Abstract] [Full Text] [Related]

  • 2. Dopamine transporter genotype influences the physiological response to medication in ADHD.
    Gilbert DL, Wang Z, Sallee FR, Ridel KR, Merhar S, Zhang J, Lipps TD, White C, Badreldin N, Wassermann EM.
    Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197
    [Abstract] [Full Text] [Related]

  • 3. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, Halperin JM, Newcorn JH.
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [Abstract] [Full Text] [Related]

  • 4. Restoration of disturbed intracortical motor inhibition and facilitation in attention deficit hyperactivity disorder children by methylphenidate.
    Buchmann J, Gierow W, Weber S, Hoeppner J, Klauer T, Benecke R, Haessler F, Wolters A.
    Biol Psychiatry; 2007 Nov 01; 62(9):963-9. PubMed ID: 17719015
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: an event-related potential study using the Attention Network Test.
    Kratz O, Studer P, Baack J, Malcherek S, Erbe K, Moll GH, Heinrich H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr 27; 37(1):81-9. PubMed ID: 22227291
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-acting methylphenidate in adults with attention deficit hyperactivity disorder: a study with paired-pulse transcranial magnetic stimulation.
    Schneider MK, Retz W, Gougleris G, Verhoeven WM, Tulen JH, Rösler M.
    Neuropsychobiology; 2011 Apr 27; 64(4):195-201. PubMed ID: 21912187
    [Abstract] [Full Text] [Related]

  • 7. Interplay of neuronal processes during response inhibition: results from a combined event-related potentials (ERPs)/transcranial magnetic stimulation (TMS) study on methylphenidate.
    Hoegl T, Heinrich H, Albrecht B, Diruf M, Moll GH, Kratz O.
    Int J Psychophysiol; 2011 Aug 27; 81(2):99-106. PubMed ID: 21620906
    [Abstract] [Full Text] [Related]

  • 8. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
    Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer MJ, Simmons A, Rubia K.
    Cereb Cortex; 2014 Jan 27; 24(1):174-85. PubMed ID: 23048018
    [Abstract] [Full Text] [Related]

  • 9. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A, Cubillo A, Barrett N, Giampietro V, Simmons A, Brammer M, Rubia K.
    Biol Psychiatry; 2013 Oct 15; 74(8):615-22. PubMed ID: 23731741
    [Abstract] [Full Text] [Related]

  • 10. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
    Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer M, Simmons A, Rubia K.
    Psychol Med; 2014 Feb 15; 44(3):633-46. PubMed ID: 23597077
    [Abstract] [Full Text] [Related]

  • 11. Atomoxetine treatment of ADHD in Tourette syndrome: reduction in motor cortex inhibition correlates with clinical improvement.
    Gilbert DL, Zhang J, Lipps TD, Natarajan N, Brandyberry J, Wang Z, Sallee FR, Wassermann EM.
    Clin Neurophysiol; 2007 Aug 15; 118(8):1835-41. PubMed ID: 17588810
    [Abstract] [Full Text] [Related]

  • 12. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun 15; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 13. Reduced short interval cortical inhibition correlates with atomoxetine response in children with attention-deficit hyperactivity disorder (ADHD).
    Chen TH, Wu SW, Welge JA, Dixon SG, Shahana N, Huddleston DA, Sarvis AR, Sallee FR, Gilbert DL.
    J Child Neurol; 2014 Dec 15; 29(12):1672-9. PubMed ID: 24413361
    [Abstract] [Full Text] [Related]

  • 14. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
    Bédard AC, Stein MA, Halperin JM, Krone B, Rajwan E, Newcorn JH.
    J Child Psychol Psychiatry; 2015 Jan 15; 56(1):40-8. PubMed ID: 24942409
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV, Glatt SJ.
    J Clin Psychiatry; 2010 Jun 15; 71(6):754-63. PubMed ID: 20051220
    [Abstract] [Full Text] [Related]

  • 16. Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate.
    Prescrire Int; 2010 Feb 15; 19(105):5-8. PubMed ID: 20455329
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Attention-deficit/hyperactivity disorder: use of cognitive evoked potential (P300) to predict treatment response.
    Sangal RB, Sangal JM.
    Clin Neurophysiol; 2006 Sep 15; 117(9):1996-2006. PubMed ID: 16890481
    [Abstract] [Full Text] [Related]

  • 19. [Transcranial magnetic stimulation in child and adolescent psychiatry: excitability of the motor system in tic disorders and/or attention deficit hyperactivity disorders].
    Moll GH, Heinrich H, Rothenberger A.
    Z Kinder Jugendpsychiatr Psychother; 2001 Nov 15; 29(4):312-23. PubMed ID: 11763610
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.